The 2022 global mpox outbreak underscored the challenge of distinguishing between monkeypox virus infection and vaccination-induced immunity due to cross-reactive antibodies. Here, the authors develop a machine learning-assisted serological assay that differentiates MPXV infection from vaccination, achieving 88% specificity and 92% sensitivity, paving the way for seroepidemiological studies with improved resolution.
- Rebecca Surtees
- Fridolin Treindl
- Daniel Stern
